1. Home
  2. JSPR vs GHI Comparison

JSPR vs GHI Comparison

Compare JSPR & GHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JSPR
  • GHI
  • Stock Information
  • Founded
  • JSPR 2018
  • GHI 1998
  • Country
  • JSPR United States
  • GHI United States
  • Employees
  • JSPR N/A
  • GHI N/A
  • Industry
  • JSPR Biotechnology: Biological Products (No Diagnostic Substances)
  • GHI Finance: Consumer Services
  • Sector
  • JSPR Health Care
  • GHI Finance
  • Exchange
  • JSPR Nasdaq
  • GHI Nasdaq
  • Market Cap
  • JSPR 342.2M
  • GHI 287.2M
  • IPO Year
  • JSPR N/A
  • GHI N/A
  • Fundamental
  • Price
  • JSPR $23.97
  • GHI $11.75
  • Analyst Decision
  • JSPR Strong Buy
  • GHI Strong Buy
  • Analyst Count
  • JSPR 10
  • GHI 4
  • Target Price
  • JSPR $74.86
  • GHI $17.50
  • AVG Volume (30 Days)
  • JSPR 213.6K
  • GHI 103.2K
  • Earning Date
  • JSPR 11-07-2024
  • GHI 11-06-2024
  • Dividend Yield
  • JSPR N/A
  • GHI 12.49%
  • EPS Growth
  • JSPR N/A
  • GHI N/A
  • EPS
  • JSPR N/A
  • GHI 0.61
  • Revenue
  • JSPR N/A
  • GHI $34,307,528.00
  • Revenue This Year
  • JSPR N/A
  • GHI N/A
  • Revenue Next Year
  • JSPR N/A
  • GHI $10.35
  • P/E Ratio
  • JSPR N/A
  • GHI $19.33
  • Revenue Growth
  • JSPR N/A
  • GHI 28.98
  • 52 Week Low
  • JSPR $4.00
  • GHI $10.92
  • 52 Week High
  • JSPR $31.01
  • GHI $17.48
  • Technical
  • Relative Strength Index (RSI)
  • JSPR 61.84
  • GHI 42.82
  • Support Level
  • JSPR $19.12
  • GHI $11.60
  • Resistance Level
  • JSPR $23.60
  • GHI $11.96
  • Average True Range (ATR)
  • JSPR 1.61
  • GHI 0.26
  • MACD
  • JSPR 0.06
  • GHI 0.09
  • Stochastic Oscillator
  • JSPR 83.91
  • GHI 70.94

About JSPR Jasper Therapeutics Inc.

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.

About GHI Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests

Greystone Housing Impact Investors LP engaged in acquiring a portfolio of mortgage revenue bonds (MRBs) that are issued by state and local housing authorities to provide construction and/or permanent financing for affordable multifamily housing, seniors housing, and commercial properties. It has four reportable segments, namely Affordable Multifamily MRB Investments, Seniors and Skilled Nursing MRB Investments, MF Properties, and Market-Rate Joint Venture Investments. It generates the majority of its revenue from the Affordable Multifamily MRB Investments segment.

Share on Social Networks: